Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IL-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | IL-1 |
| Key Genes/Proteins | Actin, AEP, AGING, AIF, AIM2, Akt |
| Related Diseases | Addiction, Aging, Als |
Knowledge base pages for this entity
graph TD
IL_1["IL-1"]
style IL_1 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
IL_1 -->|"contributes to"| Atherosclerosis["Atherosclerosis"]
IL_1 -->|"mediates"| Inflammatory_Senescence_Associ(Inflammatory Senescence-Associated Secretory Phenotype)
IL_1 -->|"activates"| Ms["Ms"]
IL_1 -->|"activates"| Tumor["Tumor"]
IL_1 -->|"activates"| Inflammation["Inflammation"]
IL_1 -->|"activates"| Alzheimer["Alzheimer"]
IL_1 -->|"activates"| Aging["Aging"]
IL_1 -->|"activates"| Phagocytosis["Phagocytosis"]
IL_1 -->|"activates"| OCLN([OCLN])
IL_1 -->|"activates"| MLCK([MLCK])
NLRP3([NLRP3]) -->|"activates"| IL_1
IL_17([IL-17]) -->|"co_expressed_with"| IL_1
DISEASE_ASSOCIATED_MICROGLIA([DISEASE-ASSOCIATED MICROGLIA]) -->|"activates"| IL_1
TNFR1([TNFR1]) -->|"activates"| IL_1
AND([AND]) -->|"activates"| IL_1
MICROGLIA([MICROGLIA]) -->|"activates"| IL_1
MYELIN([MYELIN]) -->|"activates"| IL_1
CYTOKINES([CYTOKINES]) -->|"activates"| IL_1
NEURODEGENERATIVE_DISEASES([NEURODEGENERATIVE DISEASES]) -->|"activates"| IL_1
PHAGOCYTOSIS([PHAGOCYTOSIS]) -->|"activates"| IL_1| Target | Relation | Type | Str |
|---|---|---|---|
| IL-1 | encodes | protein | 0.00 |
| Systemic Inflammation | mediates | process | 0.85 |
| Cognitive Impairment | associated_with | phenotype | 0.85 |
| Senescence-associated secretory phenotype | regulates | phenotype | 0.80 |
| Atherosclerosis | contributes_to | disease | 0.80 |
| MICROGLIA | upregulates | cell_type | 0.80 |
| Inflammatory Senescence-Associated Secretory Phenotype | mediates | phenotype | 0.80 |
| Fibrosis | causes | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.65 |
| Ischemia | expressed_in | disease | 0.65 |
| Pyroptosis | inhibits | disease | 0.65 |
| Multiple Sclerosis | therapeutic_target | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Ferroptosis | activates | disease | 0.65 |
| Ferroptosis | therapeutic_target | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Autoimmune | activates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Pyroptosis | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Dementia | contributes_to | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| IL-1 | encodes | gene | 0.00 |
| NLRP3 | activates | protein | 0.90 |
| Mitochondrial dysfunction-associated senescence | inhibits | phenotype | 0.85 |
| NF-κB | upregulates | protein | 0.85 |
| IL-17 | interacts_with | protein | 0.80 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.74 |
| ALS | associated_with | disease | 0.66 |
| NF-KB | associated_with | protein | 0.66 |
| TBK1 | expressed_in | gene | 0.60 |
| DEPRESSION | inhibits | gene | 0.60 |
| STING | expressed_in | gene | 0.60 |
| TLR4 | inhibits | gene | 0.60 |
| MITOPHAGY | inhibits | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| IRF3 | expressed_in | gene | 0.60 |
| RELA | activates | gene | 0.60 |
| IL-10 | associated_with | gene | 0.60 |
| WNT | activates | gene | 0.60 |
| LDLR | inhibits | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| MYELIN | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| TNC | inhibits | gene | 0.60 |
| NEAT1 | activates | gene | 0.60 |
| TNFR1 | activates | gene | 0.60 |
| DISEASE-ASSOCIATED MICROGLIA | activates | gene | 0.60 |
| IRF3 | activates | gene | 0.60 |
| INFLAMMATION | interacts_with | gene | 0.60 |
| ROS | inhibits | gene | 0.60 |
| C1Q | activates | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | activates | gene | 0.60 |
| MITOCHONDRIA | inhibits | gene | 0.60 |
| AMPK | inhibits | gene | 0.60 |
| ASTROCYTE | expressed_in | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| DEPRESSION | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| NAD | activates | gene | 0.60 |
| IBA1 | expressed_in | gene | 0.60 |
| CD14 | activates | gene | 0.60 |
| ROS | biomarker_for | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
| SYN1 | biomarker_for | gene | 0.60 |
| MITOCHONDRIA | activates | gene | 0.60 |
| IRF7 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 14 hypotheses Top: 0.806
neurodegeneration | 2026-04-01 | 14 hypotheses Top: 0.729
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Network pharmacology analysis of QTJD active compounds and pathways | exploratory | Mycoplasma pneumoniae pneumoni | 0.900 | 0.00 | computational network analysis | proposed | N/A |
| IL-10 deficiency and VLC ceramide accumulation in inflammatory bowel d | validation | inflammatory bowel disease | 0.900 | 0.00 | IL-10 knockout mice | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.76 · 2026-04-23
closed · Rounds: 7 · Score: 0.87 · 2026-04-16
closed · Rounds: 4 · Score: 0.90 · 2026-04-06
Hypotheses and analyses mentioning IL-1 in their description or question text
Score: 0.617 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The proposed LRP1/NLRP3/IL-1β cascade represents a critical mechanistic link betw
Score: 0.610 · neurodegeneration · 2026-04-28
NLRP3 inflammasome activation releases IL-1β, driving complement cascade upregulation and synapse elimination. MCC950 or
Score: 0.565 · immunomics · 2026-04-25
Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification
Score: 0.506 · neuroinflammation · 2026-04-14
## Mechanistic Overview TYRO3-STAT1 Axis to Preserve Parvalbumin Interneuron Function by Suppressing IL-1β-Mediated Infl
Score: 0.380 · immunomics · 2026-04-26
Rather than depleting CCR2+ monocytes, this hypothesis proposes reprogramming their phenotype through targeted IL-10 pat
Score: 0.380 · immunomics · 2026-04-27
This hypothesis proposes that circulating hs-CRP directly recruits CCR2+ monocytes to the CNS through upregulation of CC
Score: 0.357 · immunomics · 2026-04-26
Circulating hs-CRP directly triggers CCR2+ monocyte recruitment to the CNS by enhancing CCL2 expression in brain endothe
Score: 0.000 · unknown disease · 2026-04-28
Simultaneously blocking the classical A1-inducing triad while specifically activating alternative pathways through Nrf2
Score: 0.000 · unknown disease · 2026-04-28
By first blocking IL-1α to prevent initial astrocyte activation, followed by delayed complement receptor (C3aR/C5aR) ant